Oxford BioTherapeutics, a clinical-stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate-based therapies, has entered a multi-year collaboration with Roche to discover novel potentially first-in-class antibody-based therapeutics for the treatment of cancer. ?? https://hubs.li/Q03cZw5s0 #pharmanews #oncology #ADCs
Contract Pharma
媒体制作
Montvale，New Jersey 9,771 位关注者
From drug development to manufacturing, we cover the latest developments, views & opinions from the pharma industry
关于我们
CONTRACT PHARMA is the multi media information outlet dedicated to bio/pharma outsourcing. From drug development to manufacturing, we cover the latest developments, views and opinions from industry leaders in print and online. CONTRACT PHARMA offers advertising opportunities in our print magazine, Contract Pharma Direct weekly e newsletter and on contractpharma.com. We are the only worldwide print publication focused on Bio/Pharma contract services, delivering a total qualified circulation of 20,013. (VAC audit statement) On Sept. 18-19, 2025 CONTRACT PHARMA will host its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition. This event brings together speakers from the FDA, industry leaders, and expert analysts to discuss issues critical to success for Pharma & Biopharma outsourcing. The one-day Tabletop Exhibition of 160 top contract service providers provides great exposure to outsourcing decision makers. CONTRACT PHARMA's Corporate Capabilities and Contract Services Directory is the largest single source for company profiles and contract services. This standalone print issue showcases the services of Bio/Pharma contract service providers. The Contract Services Directory is also available online at www.contractpharma.com/csd. It's an indispensable guide for contract services in print and online. Every week, thousands of Bio/Pharma outsourcing professionals go to www.contractpharma.com to read current features, find archive stories, and get breaking news and online exclusives. We also e-mail CONTRACT PHARMA DIRECT, our weekly e-newsletter, to more than 20,000 people. CPDirect is filled with the latest news, our most recent articles, and links to our popular annual features and upcoming meetings. Free subscriptions are available on our website. Contact us for more information on how your company can get involved with Contract Pharma.
- 网站
-
https://www.contractpharma.com/
Contract Pharma的外部链接
- 所属行业
- 媒体制作
- 规模
- 11-50 人
- 总部
- Montvale，New Jersey
- 类型
- 私人持股
- 领域
- Pharma、Contract Manufacturing、Pharmaceuticals、news和marketing
地点
-
主要
获取路线
25 Philips Pkwy
US，New Jersey，Montvale，07645
Contract Pharma员工
动态
-
Join thousands of pharmaceutical and biopharma leaders at INTERPHEX 2025—where innovation meets implementation. Whether you’re developing the next breakthrough biologic, scaling small molecule production, optimizing supply chains, or ensuring regulatory compliance, #INTERPHEX2025 is where pharma’s trailblazers connect to solve today’s challenges and shape tomorrow’s medicines. Don’t miss out! Claim your free exhibit hall badge today: https://hubs.li/Q03cWGwB0 Sponsored by INTERPHEX Global
-
-
A new report released by Ernst & Young LLP and Innovation Works, reveals that Pittsburgh’s technology ecosystem saw a record number of venture capital (VC) deals in 2024, with AI and life sciences companies leading the way. ?? https://hubs.li/Q03cTY550 #pharmanews #lifesciences #Pittsburgh
-
-
Join Grand River Aseptic Manufacturing & LTS Device Technologies on April 2nd @ 11am EST for this exclusive webinar! As the demand for large-volume delivery grows, so does the need to standardize primary containers in the OBDS world. These two are leading the charge, balancing the need for both standardization and flexibility. Don't Miss Out!
此处无法显示此内容
在领英 APP 中访问此内容等
-
Sobi has entered a research collaboration involving a new Phase 2a clinical trial for Gamifant (emapalumab) for the potential treatment of interferon-gamma (IFNγ)-driven sepsis (IDS). ?? https://hubs.li/Q03cHwyg0 #pharmanews #sepsis #clinicaltrial
-
-
OPKO Health?and?Entera Bio, a developer of oral peptides and protein replacement therapies, entered into a license agreement to advance into the clinic the first oral dual agonist GLP-1/glucagon peptide as a once-daily tablet treatment for patients with obesity, metabolic, and fibrotic disorders.? https://hubs.li/Q03cz0p90
-
Couldn’t make it to #DCATWeek? Read our summary of the DCAT Member Company Announcement forum, which kicked off the event on Monday morning. ?? https://hubs.li/Q03cwTd60 #pharmanews #DCAT
-
-
As the demand for large-volume delivery grows, so does the need for standardizing primary containers in the OBDS world. Join Mary Lou Glotzbach, Sr. Manager, Drug Delivery Partnerships, from Grand River Aseptic Manufacturing and Greg Moakes, Ph.D. EVP, New Business Development, from LTS Device Technologies on Wednesday, April 2nd to explore how collaboration can drive innovation and efficiency! Register Now>> https://hubs.li/Q03bJs7V0 Sponsored by Grand River Aseptic Manufacturing & LTS Device Technologies
-
-
Delpharm, a CDMO, has reached an agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville. ?? https://hubs.li/Q03cmJld0 #pharmanews #CDMO #healthcare
-
Exogenus Therapeutics, a Portuguese biotech company, and Lonza, a global development and manufacturing company, have entered a partnership to develop Exo-101, Exogenus’ exosome-based lead candidate. ?? https://hubs.li/Q03chpTX0 #pharmanews #biotech #exosome #drugdevelopment
-